drugset / Trial / NCT00146198

Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia Repair

NCT00146198

Phase 2 Completed 40 enrolled AlgoRx Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Hernia repair is one of the most common operations. Whilst there are few complications, pain may last for several weeks and extend the period of convalescence. ALGRX 4975 is an ultra-pure form of capsaicin, which is a pain medicine that has the potential for long-term pain relief following a single administration. This study will determine whether ALGRX 4975 can provide pain relief following hernia repair.

Timeline

Start
2005-09
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule Other

Indications

No indication recorded.